“Take two and call me in the morning.” That’s the phrase that came to mind while preparing a particular article recently. While “Coating for Consumption” doesn’t deal with taking two pills and calling the doctor in the morning, I couldn’t help but think about how far we’ve come since the days when that phrase reflected what most people thought was “modern healthcare.”
Nemicon continues to push the envelope in high-performance miniaturization with its 7S Series Incremental Rotary Encoder. At just 7.2mm in diameter, and based on Nemicon’s successful line of 18mm and 12mm diameter miniature encoders, the 7S Series shaft type encoder features high resolution, high noise immunity and high reliability.
To meet the needs of today’s healthcare professionals, medical instrumentation is getting smaller and made to be portable. That means the components in them need to be smaller, while still maintaining a high level of precision. This article will look at micro valve technology in portable medical devices.
Systems such as a beating heart or a power grid that depend on the synchronized movement of their parts could fall prey to an invisible and chaotic tug-of-war known as a "chimera."
St. Jude Medical (NYSE:STJ) has announced U.S. Food and Drug Administration (FDA) approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The new devices are designed to lower the risk of lead abrasion and to ensure high-voltage therapy delivery.
Barco has announced the launch of “CareConnex, powered by Hospedia”, a fully integrated interactive patient care enterprise solution designed to support a better patient experience and improve hospital efficiency and profitability.
Techne, which makes medical testing and diagnostic products, said Tuesday that it reached a deal to buy Bionostics Holdings Ltd. and its operating subsidiary Bionostics Inc. for $104 million in cash.
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has obtained CE marking for REVIVE SE, a next-generation self-expanding clot removal device for use in treating acute ischemic stroke.
Covidien (NYSE:COV) has announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline embolization device have been published in the June issue of Radiology.
The scientific cooperation between chemists, biotechnologists, and physicists from various Catalan institutes, headed by Pau Gorostiza, from the Institute for Bioengineering of Catalonia (IBEC), and Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona), has led to a breakthrough that will favor the development of light-regulated therapeutic molecules.
Binder-USA has announced the addition of crimp termination to a variety of M16 connectors. Expanding the M16 product line with crimp termination will offer more options for factory production and increase productivity by simplifying assembly of the connectors.
Custom sapphire optics that are unaffected by most body fluids, acids and alkalis, transmit over a broad spectrum, and can be precision fabricated are available from Meller Optics. Meller Sapphire Optics for medical instruments are superior to most other materials because of the inherent durability of sapphire which is Moh 9 hardness...
TruFlow meters from Nordson enable monitoring and control of material flow during all phases and line speeds of production for nonwovens, book and product assembly, as well as for packaging applications. This variation management capability allows manufacturers to measure, understand, and improve material delivery and dispensing...
Spinal implant manufacturer Globus Medical may have to pay $16 million after a jury decided that three of its products infringed on the patents held by DePuy Synthes Products LLC, a unit of Johnson & Johnson Inc.
Boston Scientific Vercise DBS System Demonstrates Improvement in Motor Function for Patients with Parkinson's DiseaseJune 18, 2013 12:00 am | by PR Newswire | News | Comments
Patients with Parkinson's disease using the Boston Scientific Corporation Vercise™ DBS (deep brain stimulation) System showed a significant improvement in motor scores according to interim data from the VANTAGE DBS study. The Vercise DBS System incorporates multiple independent current control, which is designed to selectively stimulate targeted areas in the brain, providing physicians with fine control of stimulation.